Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$9.33 - $12.48 $221,447 - $296,212
-23,735 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $2,635 - $4,949
-325 Reduced 1.35%
23,735 $279,000
Q1 2019

May 09, 2019

SELL
$13.69 - $20.06 $82,345 - $120,660
-6,015 Reduced 20.0%
24,060 $338,000
Q1 2018

May 14, 2018

BUY
$13.8 - $16.99 $415,035 - $510,974
30,075 New
30,075 $501,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.